Skip to content

Joseph Papa

Valeant Pharmaceuticals Announces Expanded Discounts For Nitropress And Isuprel

Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) (“Valeant” or the “Company”) has announced that, pursuant to a recommendation by its Patient Access and Pricing Committee, the company will make
Read More